Effect of ruboxistaurin (RBX) On visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2). (Q53434854)
Jump to navigation
Jump to search
scientific article published in June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of ruboxistaurin (RBX) On visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2). |
scientific article published in June 2011 |
Statements
Effect of ruboxistaurin (RBX) On visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2). (English)
1 reference
Matthew J Sheetz
1 reference
Lloyd Paul Aiello
1 reference
Nazila Shahri
1 reference
Matthew D Davis
1 reference
Keri A Kles
1 reference
Ronald P Danis
1 reference
Mbdv Study Group
1 reference
1 June 2011
1 reference
1 reference
31
1 reference
1053-1059
1 reference
6
1 reference
Identifiers
1 reference